Catalyst Wire Dossier Catalyst Wire Dossier

RO5027838

· Hoffmann-La Roche
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RO5027838, covering 2016-07-28 to 2016-07-28. Get the full timeline:

Most recent: Clinical Trial Update: A Study of RO5093151 and RO5027838 in Patients With Type 2 Diabetes Mellitus on a Stable Dose of Metformin [Phase 2]

See pricing